Fred Aslan, CEO: Artiva Biotherapeutics ARTV Planned sale · Filed 25/10/17

Trade details

Type: Planned sale notice
Stock: Artiva Biotherapeutics ARTV
Person: Fred AslanCEO
Planned sale date: 25/10/17
Filed: 25/10/17

More to sell after $69.6K in 3 months

Artiva Biotherapeutics trades, last 26 weeks

What else happened in Artiva Biotherapeutics around then

Filed or reported within 30 days of the trade day · 25/09/17~25/11/16

Fred Aslan's recent trades

Fred AslanCEO
Planned sale10b5-1 planArtiva Biotherapeutics
Planned sale10b5-1 plan
Artiva Biotherapeutics
ARTV
$262.2K
23,429 sh
$262.2K
Filed 09/08
Traded 09/08
Fred AslanCEO
SellArtiva Biotherapeutics
Sell
Artiva Biotherapeutics
ARTV
$244.3K
27,116 sh
$244.3K
Filed 05/19
Traded 05/19
Fred AslanCEO
Planned saleArtiva Biotherapeutics
Planned sale
Artiva Biotherapeutics
ARTV
$258.2K
28,000 sh
$258.2K
Filed 05/18
Traded 05/18
Fred AslanPresident and CEO
Sell10b5-1 planArtiva Biotherapeutics
Sell10b5-1 plan
Artiva Biotherapeutics
ARTV
$19.1K
3,187 sh
$19.1K
Filed 25/12/15
Traded 25/12/15
Fred AslanCEO
Planned sale10b5-1 planArtiva Biotherapeutics
Planned sale10b5-1 plan
Artiva Biotherapeutics
ARTV
$42.1K
12,749 sh
$42.1K
Filed 25/12/15
Traded 25/12/15

Fred Aslan, CEO — plans to sell 25,500 sh of Artiva Biotherapeutics ARTV · $70.6K · around 10/17 · 10b5-1 plan | Whalegun